Choriocapillaris Flow Signal Deficits Are Associated With AMD Onset and Early Progression Over Three Years: ALSTAR2 Follow-Up
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.3.51 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Jiaxin Pu and 9 co-authors. Institution: Department of Ophthalmology and Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States. Major MEDLINE topics: Choroid, Macular Degeneration, Regional Blood Flow. Cited 3 times so far (Crossref); 92 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS.
Abstract (original language)
Purpose
To determine if a baseline choriocapillaris flow signal deficits (CCFD%), as a marker of impaired transport, is associated with age-related macular degeneration (AMD) onset and progression at the 3-year follow-up.
Methods
Participants ≥ 60 years old with normal macular health, early AMD (eAMD), and intermediate AMD (iAMD) were staged at baseline and follow-up with the Age-Related Eye Disease Study (AREDS) 9-step classification system and were then classified as stable and progressing based on whether their stage advanced. Spectral-domain optical coherence tomography angiography (OCTA) quantified baseline CCFD% across the Early Treatment Diabetic Retinopathy Study (ETDRS) central subfield (CS), inner ring (IR), and an outer area (OA, extending superiorly). Adjusted baseline CCFD% values were compared between stable and progressing eyes.
Results
Of 332 included eyes at baseline (mean age, 71.1 ± 5.8 years), 173 eyes were normal, 101 were eAMD, and 58 were iAMD. Over 3 years, 284 eyes remained stable (85.5%), and 48 eyes progressed (14.5%). In the overall cohort, progressing eyes demonstrated significantly higher baseline CCFD% than stable eyes in the CS (57.7% vs. 53.5%; P = 0.007) and IR (56.1% vs. 53.9%; P = 0.045), but not in the OA. When stratified by baseline AMD stage, stable versus progressor differences were exclusively observed in eAMD (51.4% vs. 60.7% and 52.6 vs. 58.0% for CS and IR, respectively) but not in OA or in normal eyes (all P > 0.05).
Conclusions
CCFD% in the CS and IR, one aspect of impaired transport between circulation and photoreceptors, is associated with AMD progression in early-stage disease; this spatial specificity implicates the fovea.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Ophthalmology and Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
- Department of Ophthalmology, University Hospital Bonn, Bonn, Germany.
- UCLA Doheny Eye Institute, Los Angeles, California, United States.
- Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California, United States.
- Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, United States.
- Retina Consultants of Alabama, Birmingham, Alabama, United States.
Funding
- NEI NIH HHS
Cite
APA
Pu, J., Gao, L., Thomas, T. N., Goerdt, L., Corradetti, G., Kar, D., McGwin, G., Crosson, J. N., Owsley, C., & Curcio, C. A. (2026). Choriocapillaris Flow Signal Deficits Are Associated With AMD Onset and Early Progression Over Three Years: ALSTAR2 Follow-Up. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.3.51
Vancouver
Pu J, Gao L, Thomas TN, Goerdt L, Corradetti G, Kar D, et al. Choriocapillaris Flow Signal Deficits Are Associated With AMD Onset and Early Progression Over Three Years: ALSTAR2 Follow-Up. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.3.51
BibTeX
@article{Pu2026,
author = {Pu, Jiaxin and Gao, Liyan and Thomas, Tracy N and Goerdt, Lukas and Corradetti, Giulia and Kar, Deepayan and McGwin, Gerald and Crosson, Jason N and Owsley, Cynthia and Curcio, Christine A},
title = {Choriocapillaris Flow Signal Deficits Are Associated With AMD Onset and Early Progression Over Three Years: ALSTAR2 Follow-Up},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.3.51}
}
EUVIMED